The design of accurate and robust analytical methodology is instrumental to developing orally inhaled and nasal drug products (OINDPs) and their appropriate control programmes.
David Christopher
Advertisement
Articles by David Christopher
Advertisement
Latest Updated Articles
Quality by Design for analytical methods for use with orally inhaled and nasal drug productsPublished: October 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
PharmTech Weekly News Roundup — Week of November 10, 2025
3
Share Your Perspective on the Commissioner’s National Priority Vouchers Program
4
BBB-Crossing Tech for Lysosomal Storage Disorders at Center of Chiesi–Aliada Partnership
5
